Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6579)
All Articles published online
|
Jul 14, 2012 (publication date) through Dec 1, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Phillips RJ, Helbig KJ, Hoek KHVD, Seth D, Beard MR. Osteopontin increases hepatocellular carcinoma cell growth in a CD44 dependant manner. World J Gastroenterol 2012; 18(26): 3389-3399 [PMID: 22807608 DOI: 10.3748/wjg.v18.i26.3389] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i26/3389.htm |
| Number | Citing Articles |
| 1 |
Etel Gimba, Mariana Brum, Gabriela Nestal De Moraes. Full-length osteopontin and its splice variants as modulators of chemoresistance and radioresistance (Review). International Journal of Oncology 2018; doi: 10.3892/ijo.2018.4656
|
| 2 |
GAIPING WANG, SHASHA CHEN, CONGCONG ZHAO, XIAOFANG LI, WEIMING ZHAO, JING YANG, CUIFANG CHANG, CUNSHUAN XU. Comparative analysis of gene expression profiles of OPN signalling pathway in four kinds of liver diseases. Journal of Genetics 2016; 95(3): 741 doi: 10.1007/s12041-016-0673-7
|
| 3 |
Devanshi Seth, Alastair Duly, Paul C Kuo, Geoffrey W McCaughan, Paul S Haber. Osteopontin is an important mediator of alcoholic liver disease <italic>via</italic> hepatic stellate cell activation. World Journal of Gastroenterology 2014; 20(36): 13088-13104 doi: 10.3748/wjg.v20.i36.13088
|
| 4 |
Ravi Thakur, Durga Prasad Mishra. Matrix reloaded: CCN, tenascin and SIBLING group of matricellular proteins in orchestrating cancer hallmark capabilities. Pharmacology & Therapeutics 2016; 168: 61 doi: 10.1016/j.pharmthera.2016.09.002
|
| 5 |
Marco Antonio Briones-Orta, S. Eréndira Avendaño-Vázquez, Diana Ivette Aparicio-Bautista, Jason D. Coombes, Georg F. Weber, Wing-Kin Syn. Osteopontin splice variants and polymorphisms in cancer progression and prognosis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2017; 1868(1): 93 doi: 10.1016/j.bbcan.2017.02.005
|
| 6 |
Zhuolun Song, Wei Chen, Dipti Athavale, Xiaodong Ge, Romain Desert, Sukanta Das, Hui Han, Natalia Nieto. Osteopontin Takes Center Stage in Chronic Liver Disease. Hepatology 2021; 73(4): 1594 doi: 10.1002/hep.31582
|
| 7 |
Anand Mehta, Harmin Herrera, Timothy Block. Glycosylation and Cancer. Advances in Cancer Research 2015; 126: 257 doi: 10.1016/bs.acr.2014.11.005
|
| 8 |
Kelli A. Lytle, Carmen P. Wong, Donald B. Jump, Anna Alisi. Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice. PLOS ONE 2017; 12(4): e0173376 doi: 10.1371/journal.pone.0173376
|
| 9 |
Arya Mariam Roy, Renuka Iyer, Sayan Chakraborty. The extracellular matrix in hepatocellular carcinoma: Mechanisms and therapeutic vulnerability. Cell Reports Medicine 2023; 4(9): 101170 doi: 10.1016/j.xcrm.2023.101170
|
| 10 |
Soo Im Choi, Seo Yoen Kim, Jei Ha Lee, Jung Yul Kim, Eun Wie Cho, In-Gyu Kim. Osteopontin production by TM4SF4 signaling drives a positive feedback autocrine loop with the STAT3 pathway to maintain cancer stem cell-like properties in lung cancer cells. Oncotarget 2017; 8(60): 101284 doi: 10.18632/oncotarget.21021
|
| 11 |
Byunghyun Jang, Dayoung Yoon, Ji Yoon Lee, Jiwon Kim, Jisoo Hong, Harim Koo, Jason K. Sa. Integrative multi-omics characterization reveals sex differences in glioblastoma. Biology of Sex Differences 2024; 15(1) doi: 10.1186/s13293-024-00601-7
|
| 12 |
Shunyan Weng, Liang Zhou, Lei Han, Yunsheng Yuan. Expression and purification of non-tagged recombinant mouse SPP1 inE. coliand its biological significance. Bioengineered 2014; 5(6): 405 doi: 10.4161/bioe.34424
|
| 13 |
Yu Ri Choi, Hyun-Jong Kim, Guk Young Ahn, Min Jeong Lee, Ju Ri Park, Dae-Ryong Jun, Tae-Kyoung Ryu, Joo Woong Park, Eunji Shin, Sung-Wook Choi. Fabrication of dihydroxyflavone-conjugated hyaluronic acid nanogels for targeted antitumoral effect. Colloids and Surfaces B: Biointerfaces 2018; 171: 690 doi: 10.1016/j.colsurfb.2018.08.003
|
| 14 |
Lisa Efriani Puluhulawa, I Made Joni, Khaled M. Elamin, Ahmed Fouad Abdelwahab Mohammed, Muchtaridi Muchtaridi, Nasrul Wathoni. Chitosan–Hyaluronic Acid Nanoparticles for Active Targeting in Cancer Therapy. Polymers 2022; 14(16): 3410 doi: 10.3390/polym14163410
|
| 15 |
Jawed Iqbal, Steven McRae, Thi Mai, Krishna Banaudha, Mehuli Sarkar-Dutta, Gulam Waris, Neerja Kaushik-Basu. Role of Hepatitis C Virus Induced Osteopontin in Epithelial to Mesenchymal Transition, Migration and Invasion of Hepatocytes. PLoS ONE 2014; 9(1): e87464 doi: 10.1371/journal.pone.0087464
|
| 16 |
Tetsuya Ikemoto, Mitsuo Shimada, Shinichiro Yamada. Pathophysiology of recurrent hepatocellular carcinoma after radiofrequency ablation. Hepatology Research 2017; 47(1): 23 doi: 10.1111/hepr.12705
|
| 17 |
Ana Clara Santos da Fonseca Bastos, Amanda Vitória Pampolha Gomes, Gabriela Ribeiro Silva, Mariana Emerenciano, Luciana Bueno Ferreira, Etel Rodrigues Pereira Gimba. The Intracellular and Secreted Sides of Osteopontin and Their Putative Physiopathological Roles. International Journal of Molecular Sciences 2023; 24(3): 2942 doi: 10.3390/ijms24032942
|
| 18 |
Sumiko Nagoshi. Osteopontin: Versatile modulator of liver diseases. Hepatology Research 2014; 44(1): 22 doi: 10.1111/hepr.12166
|
| 19 |
KUN DING, LU FAN, SHIJUN CHEN, YANNA WANG, HAIFENG YU, YANNI SUN, JIGUANG YU, LI WANG, XIANGZHONG LIU, YOUDE LIU. Overexpression of osteopontin promotes resistance to cisplatin treatment in HCC. Oncology Reports 2015; 34(6): 3297 doi: 10.3892/or.2015.4306
|
| 20 |
Shinichiro Yamada, Tohru Utsunomiya, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yusue Arakawa, Mami Kanamoto, Shuichi Iwahashi, Yu Saito, Chie Takasu, Daichi Ishikawa, Mitsuo Shimada. Expressions of Hypoxia-Inducible Factor-1 and Epithelial Cell Adhesion Molecule are Linked with Aggressive Local Recurrence of Hepatocellular Carcinoma After Radiofrequency Ablation Therapy. Annals of Surgical Oncology 2014; 21(S3): 436 doi: 10.1245/s10434-014-3575-z
|
| 21 |
Xin-Lin Wu, Kai-Jin Lin, Ai-Ping Bai, Wan-Xiang Wang, Xing-Kai Meng, Xiu-Lan Su, Ming-Xing Hou, Pei-De Dong, Jun-Jing Zhang, Zhao-Yang Wang, Lin Shi. Osteopontin knockdown suppresses the growth and angiogenesis of colon cancer cells. World Journal of Gastroenterology 2014; 20(30): 10440-10448 doi: 10.3748/wjg.v20.i30.10440
|
| 22 |
Natalia A Osna, Murali Ganesan, Devanshi Seth, Todd A Wyatt, Srivatsan Kidambi, Kusum K Kharbanda. Second hits exacerbate alcohol-related organ damage: an update. Alcohol and Alcoholism 2021; 56(1): 8 doi: 10.1093/alcalc/agaa085
|
| 23 |
Gaiping Wang, Congcong Zhao, Shasha Chen, Xiaofang Li, Ling Zhang, Cuifang Chang, Cunshuan Xu. A preliminary in vivo study of the effects of OPN on rat liver regeneration induced by partial hepatectomy. Molecular Biology Reports 2016; 43(12): 1371 doi: 10.1007/s11033-016-4071-2
|
| 24 |
Haimei Qin, Rong Wang, Guijiang Wei, Huaifei Wang, Guogang Pan, Rentong Hu, Yesheng Wei, Renguang Tang, Junli Wang. Overexpression of osteopontin promotes cell proliferation and migration in human nasopharyngeal carcinoma and is associated with poor prognosis. European Archives of Oto-Rhino-Laryngology 2018; 275(2): 525 doi: 10.1007/s00405-017-4827-x
|